rs7503195

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000559663.2(CDK12):​n.*872-526G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.332 in 152,032 control chromosomes in the GnomAD database, including 9,718 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.33 ( 9718 hom., cov: 32)

Consequence

CDK12
ENST00000559663.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.15

Publications

10 publications found
Variant links:
Genes affected
CDK12 (HGNC:24224): (cyclin dependent kinase 12) Enables RNA polymerase II CTD heptapeptide repeat kinase activity and cyclin binding activity. Involved in phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; and regulation of MAP kinase activity. Located in nuclear speck. Part of cyclin K-CDK12 complex. [provided by Alliance of Genome Resources, Apr 2022]
CDK12 Gene-Disease associations (from GenCC):
  • Tourette syndrome
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.484 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000559663.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDK12
ENST00000559663.2
TSL:5
n.*872-526G>A
intron
N/AENSP00000453329.2

Frequencies

GnomAD3 genomes
AF:
0.333
AC:
50536
AN:
151914
Hom.:
9715
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.131
Gnomad AMI
AF:
0.360
Gnomad AMR
AF:
0.365
Gnomad ASJ
AF:
0.394
Gnomad EAS
AF:
0.471
Gnomad SAS
AF:
0.500
Gnomad FIN
AF:
0.392
Gnomad MID
AF:
0.396
Gnomad NFE
AF:
0.411
Gnomad OTH
AF:
0.365
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.332
AC:
50535
AN:
152032
Hom.:
9718
Cov.:
32
AF XY:
0.336
AC XY:
24960
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.131
AC:
5449
AN:
41514
American (AMR)
AF:
0.366
AC:
5586
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.394
AC:
1369
AN:
3472
East Asian (EAS)
AF:
0.471
AC:
2430
AN:
5156
South Asian (SAS)
AF:
0.500
AC:
2400
AN:
4798
European-Finnish (FIN)
AF:
0.392
AC:
4143
AN:
10556
Middle Eastern (MID)
AF:
0.401
AC:
118
AN:
294
European-Non Finnish (NFE)
AF:
0.411
AC:
27954
AN:
67956
Other (OTH)
AF:
0.360
AC:
758
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1583
3167
4750
6334
7917
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
510
1020
1530
2040
2550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.384
Hom.:
9147
Bravo
AF:
0.318
Asia WGS
AF:
0.457
AC:
1587
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
5.6
DANN
Benign
0.65
PhyloP100
1.2

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7503195; hg19: chr17-37722515; API